Search results
Results From The WOW.Com Content Network
The respiratory quotient (RQ or respiratory coefficient) is a dimensionless number used in calculations of basal metabolic rate (BMR) when estimated from carbon dioxide production. It is calculated from the ratio of carbon dioxide produced by the body to oxygen consumed by the body, when the body is in a steady state.
The most widely used route is orotracheal, in which an endotracheal tube is passed through the mouth and vocal apparatus into the trachea. In a nasotracheal procedure, an endotracheal tube is passed through the nose and vocal apparatus into the trachea. Alternatives to standard endotracheal tubes include laryngeal tube and combitube. [citation ...
In respiratory physiology, the ventilation/perfusion ratio (V/Q ratio) is a ratio used to assess the efficiency and adequacy of the ventilation-perfusion coupling and thus the matching of two variables: V – ventilation – the air that reaches the alveoli; Q – perfusion – the blood that reaches the alveoli via the capillaries
where RQ is the respiratory quotient (ratio of volume CO 2 produced to volume of O 2 consumed), is 21.13 kilojoules (5.05 kcal), the heat released per litre of oxygen by the oxidation of carbohydrate, and is 19.62 kilojoules (4.69 kcal), the value for fat. This gives the same result as the Weir formula at RQ = 1 (burning only carbohydrates ...
The standard procedure ensures an accurate and objectively collected set of data, based on a common reference, to reduce incompatibility of the results when shared across differing medical groups. The patient is asked to put on soft nose clips to prevent air escape and a breathing sensor in their mouth forming an air tight seal.
A ventilation/perfusion lung scan, also called a V/Q lung scan, or ventilation/perfusion scintigraphy, is a type of medical imaging using scintigraphy and medical isotopes to evaluate the circulation of air and blood within a patient's lungs, [1] [2] in order to determine the ventilation/perfusion ratio.
High-frequency oscillatory ventilation was first described in 1972 [8] and is used in neonates and adult patient populations to reduce lung injury, or to prevent further lung injury. [9] HFOV is characterized by high respiratory rates between 3.5 and 15 hertz (210 - 900 breaths per minute) and having both inhalation and exhalation maintained by ...
Pulmonary function testing is a safe procedure; however, there is cause for concern regarding untoward reactions and the value of the test data should be weighed against potential hazards. Some complications include dizziness, shortness of breath, coughing, pneumothorax, and inducing an asthma attack.